Fatty liver disease in obese children relation to other metabolic risk factors

International Journal of Pediatric Obesity

Volumn 6, Issue SUPPL. 1, 2011, Pages 59-64

  Volovelsky, Oded ^a   Weiss, Ram ^a,b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

Fatty liver; Insulin resistance; Lipid partitioning; Metabolic syndrome

Indexed keywords

CARDIOVASCULAR RISK; CONFERENCE PAPER; DYSLIPIDEMIA; FATTY LIVER; GLUCOSE METABOLISM; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID STORAGE; LIPOGENESIS; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHILD; DYSLIPIDEMIAS; FATTY LIVER; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME X; OBESITY; RISK FACTORS;

EID: 80052756491     PISSN: 17477166     EISSN: 17477174     Source Type: Journal    
DOI: 10.3109/17477166.2011.583661     Document Type: Conference Paper

References (47)

1. Roberts E. Nonalcoholic Steatohepatitis in children. Curr Gastroenterol Rep. 2003;5:253-259.
2. Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2009;50(4):1282-93.
3. Shneider BL, González-Peralta R, Roberts EA. Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: Summary of a single topic conference. Hepatology. 2006;44(5):1344-54.
4. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr. 2000;136(6):727-33.
5. Park HS, Han JH, Choi KM, Kim SM. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr. 2005;82(5):1046-51.
6. Alisi A, Manco M, Vania A, Nobili V. Pediatric nonalcoholic fatty liver disease in 2009. J Pediatr. 2009;155(4):469-74
7. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118(4):1388-93.
8. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of nonalcoholic fatty liver disease in children: A follow-up study for up to 20 years. Gut. 2009;58(11):1538-44.
9. Weiss R, Dufour S, Taksali SE et al. Prediabetes in obese youth: A syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet. 2003;362(9388):951-7.
10. Taksali SE, Caprio S, Dziura J et al. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: A determinant of an adverse metabolic phenotype. Diabetes. 2008 ;57(2):367-71.
11. Stewart SF, Vidali M, Day CP, Albano E, Jones DE. Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease. Hepatology. 2004;39:197-203.
12. Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis. 2001;21(1):57-69.
13. Day CP. From fat to inflammation Gastroenterology. 2006;130(1):207-10.
14. Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol. 2008;103(6):1372-9.
15. Calvert VS, Collantes R, Elariny H, Afendy A, Baranova A, Mendoza M, Goodman Z, Younossi ZM et al. A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis Hepatology. 2007;46(1):166-72.
16. Cortez-Pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: From cell biology to clinical practice. J Hepatol. 2006;44:197-208.
17. D'A damo E, Cali AM, Weiss R et al. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care. 2010;33(8):1817-22.
18. Fabbrini E, Magkos F, Mohammed BS et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA. 2009;106(36):15430-5.
19. Denzer C, Thiere D, Muche R et al. Gender-specific prevalences of fatty liver in obese children and adolescents: Roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab. 2009;94(10):3872-81.
20. Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation. 2008;118(3):277-83.
21. D'A damo E, Northrup V, Weiss R et al. Ethnic differences in lipoprotein subclasses in obese adolescents: Importance of liver and intraabdominal fat accretion. Am J Clin Nutr. 2010;92(3):500-8.
22. Burgert TS, Taksali SE, Dziura J et al. Alanine aminotransferase levels and fatty liver in childhood obesity: Associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006;91(11):4287-94.
23. Mazhar SM, Shiehmorteza M, Sirlin CB. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol. 2009; 7 :135-40.
24. Widhalm K, Ghods E. Nonalcoholic fatty liver disease: A challenge for pediatricians. Int J Obes 2010;34(10):1451-67.
25. Targher G, Bertolini L, Padovani R et al. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease. Diabet Med. 2006;23(4):403-9.
26. Faxon DP, Fuster V, Libby P et al. American Heart Association. Atherosclerotic Vascular Disease Conference: Writing Group III: Pathophysiology. Circulation. 2004;109(21):2617-2625.
27. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007;191(2):235-40.
28. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Haffner SM. Liver markers and development of the metabolic syndrome: The insulin resistance atherosclerosis study. Diabetes. 2005;54(11):3140-7.
29. Tabit CE, Chung WB, Hamburg NM, Vita JA. Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications. Rev Endocr Metab Disord. 2010;11(1):61-74.
30. Yesilova Z, Yaman H, Oktenli C et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease. Am J Gastroenterol. 2005;100(4): 850-5.
31. Haukeland JW, Damas JK, Konopski Z et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol. 2006;44(6):1167-74.
32. Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. 2009;6(6):399-409.
33. Pagano C, Soardo G, Esposito W et al. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol. 2005;152(1):113-8.
34. Bugianesi E, Pagotto U, Manini R et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab. 2005;90(6):3498-504.
35. Polyzos SA, Kountouras J, Zavos C, Tsiaousi E. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab. 2010;12(5): 365-83.
36. Matsunami T, Sato Y, Ariga S, Sato T, Kashimura H, Hasegawa Y, Yukawa M. Regulation of oxidative stress and inflammation by hepatic adiponectin receptor 2 in an animal model of nonalcoholic steatohepatitis. Int J Clin Exp Pathol. 2010;3(5):472-81.
37. Järvisalo MJ, Jartti L, Näntö-Salonen K et al. Increased aortic intima-media thickness: A marker of preclinical atherosclerosis in high-risk children. Circulation. 2001;104(24): 2943-7.
38. Targher G, Bertolini L, Padovani R et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care. 2006;29(6):1325-30.
39. Pacifico L, Cantisani V, Ricci P et al. Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res. 2008;63(4):423-7.
40. Demircioǧlu F, Koçyiǧit A, Arslan N, Cakmakçi H, Hizli S, Sedat AT. Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2008; 47(1):68-75.
41. Manco M, Bedogni G, Monti L, Morino G, Natali G, Nobili V. Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. Atherosclerosis. 2010;209(2):463-8.
42. Caserta CA, Pendino GM, Amante A et al. Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy. Am J Epidemiol. 2010;171(11):1195- 202.
43. Perseghin G. The role of non-alcoholic fatty liver disease in cardiovascular disease. Dig Dis. 2010;28(1):210-3.
44. Musso G, Gambino R, Cassader M, Pagano G. A metaanalysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology. 2010;52(1):79-104.
45. Nobili V, Manco M, Devito R et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial. Hepatology. 2008; 48(1):119-28.
46. van der Heijden GJ, Wang ZJ, Chu ZD et al. A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents. Obesity. 2010;18(2):384-90.
47. Vitola BE, Deivanayagam S, Stein RI et al. Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents. Obesity. 2 009; 17(9):1744-8.